21.12.2017 22:33:00
|
WeissLaw LLP: Kindred Healthcare Inc. Merger May Not Be in the Best Interests of KND Shareholders
NEW YORK, Dec. 21, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Kindred Healthcare Inc. ("KND" or the "Company") (NYSE: KND) in connection with the proposed acquisition of the Company by Humana Inc. ("HUM") (NYSE: HUM) and two private equity firms. Under the terms of the acquisition agreement, shareholders of KND will be entitled to receive $9.00 in cash for each KND share they own.
WeissLaw is investigating whether KND's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $11.00, or $2.00 above the offer price. Additionally, KND shares traded for $11.90, or nearly $3.00 above the offer price, as recently as July 3.
Given these facts, WeissLaw is investigating whether KND shareholders will obtain their fair and proportionate share of the Company's continued success and future growth prospects. If you own KND shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/kindred-healthcare-inc/
View original content:http://www.prnewswire.com/news-releases/weisslaw-llp-kindred-healthcare-inc-merger-may-not-be-in-the-best-interests-of-knd-shareholders-300574762.html
SOURCE WeissLaw LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Humana Inc.mehr Nachrichten
22.11.24 |
S&P 500-Titel Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 10 Jahren verdient (finanzen.at) | |
20.11.24 |
Börsianer in New York warten auf Impulse: S&P 500 notiert zum Ende des Mittwochshandels um seinen Schlusskurs vom Montag (finanzen.at) | |
20.11.24 |
Mittwochshandel in New York: S&P 500 fällt nachmittags zurück (finanzen.at) | |
20.11.24 |
Schwacher Handel: S&P 500 präsentiert sich mittags leichter (finanzen.at) | |
20.11.24 |
Verluste in New York: S&P 500 zeigt sich zum Start leichter (finanzen.at) | |
15.11.24 |
S&P 500-Papier Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 5 Jahren verloren (finanzen.at) | |
14.11.24 |
Schwache Performance in New York: S&P 500 zeigt sich zum Start des Donnerstagshandels leichter (finanzen.at) | |
08.11.24 |
S&P 500-Papier Humana-Aktie: So viel Verlust hätte ein Humana-Investment von vor 3 Jahren eingebracht (finanzen.at) |